The DELFIA® Neonatal 17α-OH-progesterone Assay Kit is a highly sensitive and specific tool for measuring 17α-hydroxyprogesterone (17-OHP) levels in neonatal blood spots. Utilizing time-resolved fluorescence technology, this kit ensures accurate and reliable results, making it essential for early detection of congenital adrenal hyperplasia (CAH) in newborns.

1. The kit features a robust design with high sensitivity and specificity, ensuring precise measurement of 17-OHP levels. Its time-resolved fluorescence method minimizes background noise, enhancing accuracy.
2. The kit's components include calibrators, controls, and specialized reagents such as europium-labeled tracer and rabbit polyclonal antiserum. These components work synergistically to provide reliable and reproducible results.
3. Primarily used in neonatal screening, this kit aids in the early diagnosis of CAH, a condition that can lead to severe health complications if not detected and treated promptly.

The DELFIA® Neonatal 17α-OH-progesterone Assay Kit is a vital tool in neonatal screening, offering high sensitivity and specificity for detecting 17-OHP levels. Its comprehensive components and advanced technology make it indispensable for early diagnosis of congenital adrenal hyperplasia.

The kit's main features include high sensitivity, specificity, and reliability in measuring 17-OHP levels, utilizing time-resolved fluorescence technology for accurate results.

1. High sensitivity ensures the detection of low concentrations of 17-OHP, crucial for early diagnosis.
2. Specificity is achieved through the use of europium-labeled tracers and rabbit polyclonal antiserum, minimizing cross-reactivity.
3. The time-resolved fluorescence method reduces background noise, enhancing the accuracy of measurements.
4. The kit includes comprehensive controls and calibrators, ensuring consistent and reproducible results.
5. Designed for ease of use, the kit simplifies the process of neonatal screening, making it accessible for routine clinical use.

The DELFIA® Neonatal 17α-OH-progesterone Assay Kit stands out for its high sensitivity, specificity, and reliability. Its advanced technology and user-friendly design make it an essential tool for neonatal screening and early diagnosis of congenital adrenal hyperplasia.

This kit is primarily used in neonatal screening programs to detect congenital adrenal hyperplasia (CAH) by measuring 17-OHP levels in blood spot samples.

1. Neonatal screening: The kit is widely used in hospitals and clinics for early detection of CAH in newborns.
2. Research: It is also utilized in research studies to investigate the prevalence and impact of CAH in different populations.
3. Public health: The kit supports public health initiatives by enabling large-scale screening programs for early diagnosis and intervention.
4. Clinical diagnostics: It aids in the differential diagnosis of conditions associated with abnormal 17-OHP levels.
5. Quality control: The kit's controls and calibrators ensure the accuracy and reliability of screening results, maintaining high standards in clinical practice.

The DELFIA® Neonatal 17α-OH-progesterone Assay Kit is a cornerstone in neonatal screening, research, and public health initiatives. Its application in early detection of CAH and its role in ensuring accurate diagnostics make it invaluable in clinical and research settings.

This guide provides essential information for purchasing the DELFIA® Neonatal 17α-OH-progesterone Assay Kit, including product specifications, types, budget considerations, and usage scenarios.

1. Product specifications: Ensure the kit meets your laboratory's requirements, including sensitivity, specificity, and compatibility with existing equipment.
2. Product types: Choose between different kit sizes and configurations based on your screening volume and needs.
3. Budget considerations: Evaluate the cost-effectiveness of the kit, considering its long-term benefits in neonatal screening.
4. Usage scenarios: Assess the kit's suitability for your specific clinical or research applications, ensuring it aligns with your objectives.

Purchasing the DELFIA® Neonatal 17α-OH-progesterone Assay Kit requires careful consideration of product specifications, types, budget, and usage scenarios. This guide aims to assist in making an informed decision that meets your laboratory's needs and objectives.

Proper handling and usage of the DELFIA® Neonatal 17α-OH-progesterone Assay Kit are crucial to ensure accurate and reliable results. Follow these precautions to maintain the integrity of the kit and its components.

1. Storage: Store the kit components at the recommended temperatures to preserve their stability and functionality.
2. Handling: Use aseptic techniques when handling blood spot samples to prevent contamination.
3. Calibration: Regularly calibrate the equipment used with the kit to ensure accurate measurements.
4. Disposal: Dispose of used materials and reagents according to local regulations and safety guidelines.
5. Training: Ensure that all personnel using the kit are adequately trained in its proper use and handling.

Adhering to the recommended precautions is essential for the effective use of the DELFIA® Neonatal 17α-OH-progesterone Assay Kit. Proper storage, handling, calibration, disposal, and training are key to maintaining the kit's performance and ensuring accurate neonatal screening results.